Age

40–80

Sex

ALL

Healthy volunteers

Not accepted

gastric or pancreatic cancer stage II/III, eligible for neoadjuvant chemotherapy,
age higher than 40 years and lower than 80 years,
ECOG (Eastern Cooperative Oncology Group) functional status: 0-2,
sedentary/low physical activity level.

life expectancy less than 12 months at inclusion,
chemotherapy regimen other than 5-Fluorouracil, Folinic acid, Oxaliplatin, Docetaxel (FLOT) for gastric and 5-Fluorouracil, Irinotecan and Oxaliplatin (FOLFIRINOX) or gemcitabine for pancreatic cancer,
metastatic disease,
chronic anti-inflammatory medication use,
known inflammatory condition (rheumatoid arthritis, ankylosing spondylitis or chronic active hepatitis)
cardiovascular, respiratory or musculoskeletal or joint problems that preclude moderate physical activity.

Combined Exercise and Nutritional Intervention in GI Cancer Patients